References of "REGINSTER, Jean-Yves"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailStructural and symptomatic efficacy of glucosamine and chondroitine sulfate in osteoarthrits: a comprehensive meta-analysis
Richy, Florent; Bruyère, Olivier ULg; Ethgen, Olivier ULg et al

in Osteoporosis International (2002, November), 13(Suppl.3), 55-56

Detailed reference viewed: 15 (1 ULg)
Full Text
Peer Reviewed
See detailMusculoskeletal disorders in a time demographic changes: a real challenge for the future in Europe and Northern America
Ethgen, Olivier ULg; Richy, Florent; De Ceulaer, F. et al

in Osteoporosis International (2002, November), 13(Suppl.3), 48-49

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailIs there any rationale for prescribing hormone replacement therapy (HRT) to prevent or to treat osteoarthritis?
Kvasz, Angela ULg; Bruyère, Olivier ULg; Neuprez, Audrey ULg et al

in Osteoporosis International (2002, November), 13(Suppl.3), 59

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailStrontium ranelate reduces the risk of hip fracture in women with postmenopausal osteoporosis
Reginster, Jean-Yves ULg; Sawicki, A.; Devogelaer, Jean-Pierre et al

in Osteoporosis International (2002, November), 13(Suppl.3), 14

Detailed reference viewed: 13 (0 ULg)
Full Text
Peer Reviewed
See detailThe urinary levels of type II collagen peptide COLL 2-1 and its nitrated form (COLL 2-1 NO2) are correlated with the clinical severity of knee osteoarthritis
Deberg, Michelle ULg; Christgau, Stephan; Henriksen, Dennis Bang et al

in Osteoporosis International (2002, November), 13(Suppl.3), 54

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailHigh levels of the type II collagen peptide (COLL 2-1) in serum is predictive of the radiological progressin of knee osteoarthritis
Deberg, Michelle ULg; Christgau, Stephan; Henriksen, Dennis Bang et al

in Osteoporosis International (2002, November), 13(Suppl.3), 53-54

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailDevelopment of new immunoassays for the quantification of inflammatory related cartilage degradation
Deberg, Michelle ULg; Christgau, Stephan; Cloos, Paul et al

in Osteoporosis International (2002, November), 13(Suppl. 3), 54

Detailed reference viewed: 31 (5 ULg)
Full Text
Peer Reviewed
See detailReactive oxygen species downregulate the expression of pro-inflammatry genes by humachondrocytes
Henrotin, Yves ULg; Mathy-Hartert, Marianne ULg; Martin, G. et al

in Osteoporosis International (2002, November), 13(Suppl. 3), 53

Detailed reference viewed: 24 (8 ULg)
Full Text
Peer Reviewed
See detailStructure-modifying drugs in osteoarthritis
Reginster, Jean-Yves ULg

in Osteoporosis International (2002, November), 13(Suppl.3), 9

Detailed reference viewed: 10 (4 ULg)
Full Text
Peer Reviewed
See detailCharacterization of the metabolism of osteoarthritic chondrocytes cultured in alginate beads
Henrotin, Yves ULg; Sanchez, Christelle ULg; Mathy-Hartert, Marianne et al

in Osteoporosis International (2002, November), 13(Suppl. 3), 52

Detailed reference viewed: 20 (6 ULg)
Full Text
Peer Reviewed
See detailA comparative analysis between the time trade-off and the willingness to pay approaches in hip and knee osteoarthritis
Ethgen, Olivier ULg; Tancredi, Annalisa ULg; Lejeune, Eric ULg et al

in Osteoporosis International (2002, November), 13(Suppl. 3), 47

Detailed reference viewed: 33 (8 ULg)
Full Text
Peer Reviewed
See detailEvaluation of a screening program for postmenopausal osteoporosis in primary care setting in Belgium
Goemare, S.; Kaufman, Jean-Marc; De Bacquer, D. et al

in Osteoporosis International (2002, November), 13(Suppl.3), 39

Detailed reference viewed: 4 (1 ULg)
Full Text
Peer Reviewed
See detailProspective validation in 798 postmenopausal women of a new screening tool for osteoporosis risk assessment: OSIRIS® (osteoporosis index of risk)
Reginster, Jean-Yves ULg; Viethel, P.; Micheletti, M. C. et al

in Osteoporosis International (2002, November), 13(Suppl.3), 37-38

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailHydrogen peroxide increases transforming factor-β3 gene expression in human chondrocytes and reverses interleukin-1β inhibitory effect
Mathy-Hartert, Marianne ULg; Devel, P.; Hoormaert, S. et al

in Osteoporosis International (2002, November), 13(Suppl.3), 52

Detailed reference viewed: 9 (2 ULg)
Full Text
Peer Reviewed
See detailOptimizing patient adherence and persistence in strontium ranelate phase 3 program using a short term run-in study
Reginster, Jean-Yves ULg; Spector, Tim; Badurski, J. et al

in Osteoporosis International (2002, November), 13(Suppl.3), 35-36

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailIncidence of osteoporotic non vertebral fractures coming in the strontium ranelate run-in study could validate sample size calculation
Reginster, Jean-Yves ULg; Meunier, Pierre J

in Osteoporosis International (2002, November), 13(Suppl.3), 36

Detailed reference viewed: 11 (4 ULg)
Full Text
Peer Reviewed
See detailComparison of quantitative ultrasound at the heel with a clinical risk factor score for the assessment of postmenopausal osteoporosis
Goemare, S.; Zmierczak, H.; Lauwerier, D. et al

in Osteoporosis International (2002, November), 13(Suppl.3), 36

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailA simple chart for evaluating risk of osteoporosis in Asian women based on the osteoporosis self-assement tool for Asians (OSTA)
Reginster, Jean-Yves ULg; Kung, A.; Koh, L. et al

in Osteoporosis International (2002, November), 13(Suppl.3), 30

Detailed reference viewed: 14 (0 ULg)